Innovation in Clinical Trial Methodologies Lessons Learned during the Corona Pandemic
Coordonnateur : Schueler Peter
Section 1 Introduction 1. Is the Covid pandemic an accelerator for digitalization? 2. Best practices for streamlined development
Section 2 Alternative study concepts requiring fewer patients 3. Use of historic data 4. Adaptive and platform trials 5. A vision: Studies without patients
Section 3 Studies with less patient interaction 6. Home Nursing replacing site visits 7. Telemedicine replacing site visits
Section 4 Design of "virtualized" protocols 8. Data mining for better protocols 9. Patient-centric registries for population enrichment 10. Make a protocol "patient centric" 11. The use of new digital endpoints 12. Regulations for apps in clinical trials 13. The role of the site and the patient 14. A real virtual trial
Section 5 From data to decisions 15. Data standards against data overload 16. Data analytics for operational excellence 17. Taking control of high data volume 18. Share the (digital) knowledge based on quality data
Section 6 Conclusions
Market/Audience, Primary: Pharmacologists, physicians and clinical researchers involved in the process of clinical development and clinical trial design
- Considers multiple digital and virtual strategies
- Explores best practices, including the use of reduced patient involvement
- Brings together expert, trusted information to increase the efficiency and effectiveness of clinical trials
Date de parution : 11-2020
Ouvrage de 202 p.
19x23.3 cm